Blood Cell Profiles as Predictors of Treatment Response and Outcomes in Neoadjuvant Immunotherapy with Chemotherapy for Esophageal Squamous Cell Carcinoma - Top-Institutions - MDSpire

Blood Cell Profiles as Predictors of Treatment Response and Outcomes in Neoadjuvant Immunotherapy with Chemotherapy for Esophageal Squamous Cell Carcinoma

  • By

  • Xingqiang Ran

  • Chengcheng Zhang

  • Li Zheng

  • Tao Luo

  • Binwen Xu

  • Yue Zhang

  • Liwen Zhang

  • Bo Yang

  • Maoyong Fu

  • December 11, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology
    • Immunotherapy
    • Surgical Oncology
    • Hematology
  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Immunotherapy
    • Surgical Oncology
    • Translational Research
  • #3

    Fudan University Shanghai Cancer Center
    Fudan University Shanghai Cancer Center

    Shanghai, Shanghai

    Key Differentiators

    • Oncology
    • Immunotherapy
    • Surgical Oncology
    • Hematology
  • #4

    The University of Texas Southwestern Medical Center
    The University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Oncology
    • Immunotherapy
    • Hematology
    • Surgical Oncology
  • #5

    National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences
    National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences

    Beijing, Beijing

    Key Differentiators

    • Oncology
    • Immunotherapy
    • Surgical Oncology
    • Hematology

Original Source(s)

Related Content